Clinical Research Directory
Browse clinical research sites, groups, and studies.
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation
Sponsor: University Medical Centre Ljubljana
Summary
Atrioventricular node ablation (AVNA) with biventricular (BiV) pacemaker implantation is a feasible treatment option in patients with symptomatic refractory atrial fibrillation and heart failure. However, conduction system pacing (CSP) modalities, including His bundle pacing and left bundle branch pacing, could offer advantages over BiV pacing by providing more physiological activation. The randomized, interventional, multicentric study will explore whether CSP is non-inferior to BiV pacing in echocardiographic and clinical outcomes in heart failure (EF \<50%) patients with symptomatic AF and narrow QRS scheduled for AVNA.
Official title: CONDUCTion System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation in Heart Failure Patients With Symptomatic Atrial Fibrillation and Narrow QRS (CONDUCT-AF Trial)
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
82
Start Date
2023-07-18
Completion Date
2026-12-25
Last Updated
2025-04-15
Healthy Volunteers
No
Interventions
Biventricular pacemaker implantation
Implantation of permanent pacemaker with biventricular stimulation with or without defibrillator lead placement using standard techniques. The right ventricle lead will be positioned in the RV apex or septum, while the left ventricle lead will be delivered to the most appropriate coronary sinus tributary, preferably posterolateral or lateral vein.
Conduction system pacing device implantation
Left bundle branch pacing (LBBP) will be the preferred pacing technique. In brief, after localizing the His bundle area the LBBP lead will be positioned approximately 1-1.5 cm distal to the His bundle position in the right ventricular septum. Before screwing the lead deep into the interventricular septum, the suitable position will be confirmed by fluoroscopic signs and adequate paced QSR morphology. Given that the pacing parameters with LBBP are typically low and stable, backup RV lead will not be mandatory. If LBBP will be unobtainable, His bundle pacing (HBP) implantation will be attempted. His bundle potential mapping will be performed with the use of the electrophysiological system and under fluoroscopic guidance. Distal HB potential with a large ventricular signal and a small atrial signal will be targeted before the pacing lead will be screwed into position. Backup RV lead will be mandatory for all patients receiving HBP devices.
AV node ablation
Atrioventricular node ablation (AVNA) will be performed following pacemaker implantation (preferably during the same hospitalization). After femoral vein access will be obtained, the ablation catheter will be positioned to the presumed area of the AV node in the mid-septum under fluoroscopy. The location will be optimized according to the intracardiac electrograms. Ablation will be performed in a temperature-controlled mode. Successful AVNA will be recognized with an abrupt drop of heart rate to 40 bpm and will continue for 60 seconds thereafter.
Locations (10)
University Hospital Graz - Divison of Cardiology
Graz, Austria
Hospital Oost-Limburg (Hartzentrum Genk)
Genk, Belgium
Acibadem City Clinic Tokuda Hospital - Department of Invasive Electrophysiology
Sofia, Bulgaria
Clinical Hospital Center Rijeka
Rijeka, Croatia
University Hospital of Split
Split, Croatia
University Hospital Centre Zagreb
Zagreb, Croatia
Central-Hospital of Northern Pest - Military Hospital
Budapest, Hungary
County Clinical emergency hospital of Brasov - Department of Interventional Cardiology
Brasov, Romania
University Medical Centre Ljubljana - Department of cardiology
Ljubljana, Slovenia
University Medical Centre Ljubljana - Department of cardiovascular surgery
Ljubljana, Slovenia